MILAN – The pharmaceutical group Recordati announces the death of Giovanni Recordati, 67, chairman and chief executive, following a “long illness”. And ‘what is said in a statement in which the vice-president Alberto Recordati emphasizes the “painful loss” and “very sad moment for the Group, its employees and associates. Today, the Management Board will meet at 15 to decide” about the assignment of new duties and powers. “ the entrepreneur has been CEO of the company since 1990, in 1999 had also become president. Under his management the group has grown continuously becoming an international pharmaceutical reality with branches in Europe, North America, South America and North Africa, and also in the growing field of rare diseases. “the further growth of the group in line with the development strategy outlined by our president and followed during all these years – said Andrea Recordati, chief operating officer – will continue to be pursued by us with conviction and will be our priority. “ Giovanni Recordati holds a degree in chemical engineering from the Polytechnic of Milan, he obtained a master’s degree in” Management Sciences “at Imperial College London . He joined the company in 1974 as a researcher before becoming – in 1980 – central production director in 1984 and deputy general manager for operational coordination and research. From 1977 he was a member of the board. The pharmaceutical group closed 2015 with revenues rising to over a billion and a net profit of 198 million euro share: the stock has beaten the Square Business Performance an increase of 23%. The group’s shares have increased from a minimum of 4.99 euro in May 2012 to arrive at the current share price of € 27.8.
- Topics:
- recordati
- Starring:
- john recordati
No comments:
Post a Comment